Vini Siane Tanaem
Magister of Clinical Pharmacy, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Change in Adherence and Glycemic Control Following WhatsApp-Based Education and Interactive Reminders among Diabetes Patients Diyah Wahyuni; Budi Suprapti; Ramadi Satryo Wicaksono; Abdul Kadir Jaelani; Vini Siane Tanaem
Journal of Public Health and Pharmacy Vol. 6 No. 3 (2026): In Progress
Publisher : Pusat Pengembangan Teknologi Informasi dan Jurnal Universitas Muhammadiyah Palu

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56338/jphp.v6i3.10072

Abstract

Introduction: Type 2 diabetes mellitus (DM) is a non-communicable disease with increasing prevalence and low adherence globally. Therefore, this study aims to evaluate changes in medication adherence and glycemic control after a WhatsApp-based education and interactive reminders among outpatients receiving insulin therapy. Methods: A pre-experimental study used a prospective one-group pre-test-post-test design among outpatients receiving insulin in a hospital. The intervention included DM education at the initial meeting, followed by educational videos and weekly interactive reminders provided through WhatsApp for 6 weeks. Patient knowledge was assessed with Diabetes Knowledge Questionnaire (DKQ) and adherence to medication was assessed using Adherence to Refills and Medications Scale (ARMS). Glycemic control indices (fasting blood glucose (FBG), two hours of postprandial blood glucose (2hPPBG), glycated hemoglobin (HbA1c)) were measured before and after the intervention. Additionally, a paired t-test was used to measure the effect of the intervention on knowledge, adherence, and glycemic control indices. Results: Among the 122 patients who fulfilled the inclusion criteria, there was a significant increase in knowledge (p < 0.001), with the proportion of highly knowledgeable patients rising from 19.7% to 38.5%. The increase in adherence to medication from 30.3% to 39.3% was not statistically significant (p = 0.228). Glycemic control indices showed a significant improvement (p < 0.001), with mean HbA1C, FBG, and 2hPPBG decreasing from 8.63% to 7.85%, 152.18 mg/dl to 138.72 mg/dl, and 268.84 mg/dl to 228.66 mg/dl, respectively. Conclusion: Following the 6 weeks WhatsApp-based education and interactive reminders, improvement were observed in patient knowledge and glycemic control indices, but medication adherence did not change significantly. This study lacked a control group, the findings represent observed changes after the study period and require confirmation in controlled studies with longer follow-up.
The Use of Antihypertensive Drugs in Pre-Dialysis Chronic Kidney Disease Patients Budi Suprapti; Mochammad Thaha; Wenny Putri Nilamsari; Ihsan Muhyidin; Vini Siane Tanaem; Euphrasiane Griseldis Beting
Indonesian Journal of Pharmaceutical Education Vol 6, No 2 (2026): May–August 2026
Publisher : Jurusan Farmasi Universitas Negeri Gorontalo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37311/ijpe.v6i2.38102

Abstract

In chronic kidney disease (CKD), hypertension plays a central role, acting as both a risk factor and a complication that contributes to disease progression. Effective control of blood pressure through antihypertensive therapy is essential for preserving kidney function and preventing clinical decline. Therefore, this study aimed to evaluate antihypertensive treatment and blood pressure target achievement in pre-dialysis CKD patients, with blood pressure targets defined as 130/80 mmHg and 140/80 mmHg in elderly patients. This study was a prospective observational study with a retrospective review of medical records over a 3-month period, and the data were subsequently analyzed using descriptive methods. Participants were pre-dialysis CKD patients aged 18 or older receiving antihypertensive therapy with complete blood pressure records. Among the 90 eligible patients, the most commonly used antihypertensive classes were angiotensin receptor blockers, particularly candesartan, and calcium channel blockers, specifically nifedipine, either as monotherapy or combined with two to five other antihypertensive drugs. Over three months, only an average of 23.3% of patients achieved blood pressure targets, and only 8.9% maintained that continuously. Therefore, a more effective blood pressure management strategy is needed to achieve the desired target blood pressure.